Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Biophotonics ; 16(6): e202300003, 2023 06.
Article in English | MEDLINE | ID: covidwho-2275514

ABSTRACT

Along with other COVID-19 clinical manifestations, management of both olfactory and gustatory dysfunction have drawn a considerable attention. Photobiomodulation (PBM) has emerged to be a possible effective therapy in restoring taste and smell functionality, but the evidence is scarce. Hence, the present pilot study is aimed to evaluate the effectiveness of intranasal and intraoral PBM administrations in management of anosmia and ageusia respectively. Twenty Caucasian subjects who diagnosed with anosmia and ageusia were recruited. Visual analogue scale was utilised to evaluate patients' self-reported for both olfactory and gustatory functionality. The laser-PBM parameters and treatment protocols for anosmia and ageusia were as follows respectively: 660 nm, 100 mW, two points intranasally, 60 J/session, 12 sessions; dual wavelengths (660 nm and 808 nm), 100 mW, three points intraorally, 216 J/session, 12 sessions. Our results showed a significant functionality improvement of both olfactory and gustatory functionality. Extensive studies with large data and long-term follow-up period are warranted.


Subject(s)
Ageusia , COVID-19 , Olfaction Disorders , Humans , COVID-19/complications , COVID-19/radiotherapy , Ageusia/therapy , Anosmia/radiotherapy , Pilot Projects , SARS-CoV-2 , Olfaction Disorders/radiotherapy , Olfaction Disorders/diagnosis
2.
J Biophotonics ; 15(8): e202200058, 2022 08.
Article in English | MEDLINE | ID: covidwho-1802312

ABSTRACT

It is postulated that the inflammatory process resulting from SARS-CoV-2 infection is the main cause of smell and taste dysfunctions in patients. In view of this, photobiomodulation, due to its anti-inflammatory and antioxidant effects, may be a promising therapeutic modality to treat these disorders. In the present case report, we observed clinical improvement in the symptoms of anosmia and ageusia related to COVID-19 after treatment with photobiomodulation. Due to the inflammatory nature of COVID-19 and the anti-inflammatory effects, photobiomodulation antioxidants already proven in the literature make it a promising therapeutic modality, especially sequela COVID-related, including olfactory (anosmia) and taste (ageusia) dysfunction. In the present case report, the patient's olfactory and gustatory functions were re-established after 10 treatment sessions with photobiomodulation.


Subject(s)
Ageusia , COVID-19 , Low-Level Light Therapy , Olfaction Disorders , Ageusia/etiology , Anosmia , COVID-19/complications , COVID-19/radiotherapy , Humans , Olfaction Disorders/complications , SARS-CoV-2 , Smell , Taste Disorders/complications
SELECTION OF CITATIONS
SEARCH DETAIL